MX2010001584A - Tratamiento o prevencion de infeccion por rotavirus. - Google Patents
Tratamiento o prevencion de infeccion por rotavirus.Info
- Publication number
- MX2010001584A MX2010001584A MX2010001584A MX2010001584A MX2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A
- Authority
- MX
- Mexico
- Prior art keywords
- treating
- rotavirus infection
- preventing rotavirus
- preventing
- cla
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2230/00—Aspects relating to animal feed or genotype
- A23C2230/10—Animal milk with modified composition due to a specific feed
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Animal Husbandry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Pediatric Medicine (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe el uso de uno o más del ácido linoleico conjugado (CLA), grasa de leche alta en CLA, o una o más composiciones lipídicas de leche bovina para tratar o prevenir la infección por rotavirus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ560524A NZ560524A (en) | 2007-08-09 | 2007-08-09 | Treating or preventing rotavirus infection using conjugated linoleic acid |
PCT/NZ2008/000199 WO2009020405A1 (en) | 2007-08-09 | 2008-08-08 | Treating or preventing rotavirus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010001584A true MX2010001584A (es) | 2010-03-15 |
Family
ID=40341525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010001584A MX2010001584A (es) | 2007-08-09 | 2008-08-08 | Tratamiento o prevencion de infeccion por rotavirus. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110300229A1 (es) |
EP (1) | EP2173364B1 (es) |
CN (1) | CN102159223B (es) |
AU (1) | AU2008284504A1 (es) |
BR (1) | BRPI0814935A2 (es) |
CA (1) | CA2696035A1 (es) |
DK (1) | DK2173364T3 (es) |
ES (1) | ES2699084T3 (es) |
HK (1) | HK1160788A1 (es) |
MX (1) | MX2010001584A (es) |
NZ (2) | NZ560524A (es) |
RU (1) | RU2493860C2 (es) |
TW (1) | TW200916093A (es) |
WO (1) | WO2009020405A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2702570A1 (en) * | 2007-10-19 | 2009-04-23 | Christopher Paul Mcjarrow | Methods of maintaining or increasing growth or cognitive development |
WO2010026229A1 (en) * | 2008-09-05 | 2010-03-11 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Composition richly containing polar lipid and method of manufacturing the same |
EP2389952A1 (en) * | 2010-05-31 | 2011-11-30 | Rotalactis Srl | Lactadherin-derived peptides as antiviral agents |
CN103262893B (zh) * | 2013-06-13 | 2014-11-05 | 俞祖勋 | 一种改善智力的配方奶粉 |
SE537951C2 (sv) | 2013-07-01 | 2015-12-01 | Hero Ag | Profylaktisk användning av modersmjölksersättning mot otit |
GB201611365D0 (en) * | 2016-06-30 | 2016-08-17 | Devenish Nutrition Ltd | A composition for use in treating rotavirus infection |
WO2024149806A1 (en) * | 2023-01-11 | 2024-07-18 | Frieslandcampina Nederland B.V. | Use of a phospholipid-enriched milk fraction in the prevention of an infection with rsv |
CN117838678A (zh) * | 2024-01-09 | 2024-04-09 | 江苏省农业科学院 | 神经酰胺类化合物在抑制轮状病毒感染中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4592041B2 (ja) * | 2000-11-24 | 2010-12-01 | 株式会社Nrlファーマ | 生活の質を改善する新規食品の製造法および用途 |
EP1623717B1 (en) * | 2003-03-14 | 2018-08-29 | Meiji Co., Ltd. | Composition against rotavirus infection and process for producing the same |
CA2566393A1 (en) * | 2004-05-11 | 2005-11-17 | Rupinder Kaur Kanwar | Cla-enriched milkfat and uses thereof |
US8471002B2 (en) | 2004-10-12 | 2013-06-25 | Fonterra Co-Operative Group Limited | Beta-serum dairy products, neutral lipid-depleted and/or polar lipid-enriched dairy products, and processes for their production |
NZ543486A (en) * | 2005-11-10 | 2009-03-31 | Fonterra Corporate Res And Dev | Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
-
2007
- 2007-08-09 NZ NZ560524A patent/NZ560524A/en unknown
-
2008
- 2008-08-08 ES ES08826884T patent/ES2699084T3/es active Active
- 2008-08-08 AU AU2008284504A patent/AU2008284504A1/en not_active Abandoned
- 2008-08-08 CN CN2008801109127A patent/CN102159223B/zh active Active
- 2008-08-08 MX MX2010001584A patent/MX2010001584A/es not_active Application Discontinuation
- 2008-08-08 DK DK08826884.2T patent/DK2173364T3/en active
- 2008-08-08 CA CA2696035A patent/CA2696035A1/en not_active Abandoned
- 2008-08-08 EP EP08826884.2A patent/EP2173364B1/en active Active
- 2008-08-08 US US12/672,480 patent/US20110300229A1/en not_active Abandoned
- 2008-08-08 RU RU2010108285/15A patent/RU2493860C2/ru active
- 2008-08-08 WO PCT/NZ2008/000199 patent/WO2009020405A1/en active Application Filing
- 2008-08-08 BR BRPI0814935-6A2A patent/BRPI0814935A2/pt not_active IP Right Cessation
- 2008-08-08 TW TW097130467A patent/TW200916093A/zh unknown
- 2008-08-11 NZ NZ586798A patent/NZ586798A/en unknown
-
2012
- 2012-02-09 HK HK12101278.7A patent/HK1160788A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN103479607A (zh) | 2014-01-01 |
EP2173364A1 (en) | 2010-04-14 |
NZ560524A (en) | 2011-04-29 |
ES2699084T3 (es) | 2019-02-07 |
RU2010108285A (ru) | 2011-09-20 |
EP2173364B1 (en) | 2018-10-31 |
CN102159223A (zh) | 2011-08-17 |
WO2009020405A1 (en) | 2009-02-12 |
AU2008284504A1 (en) | 2009-02-12 |
NZ586798A (en) | 2012-03-30 |
DK2173364T3 (en) | 2018-12-17 |
RU2493860C2 (ru) | 2013-09-27 |
TW200916093A (en) | 2009-04-16 |
US20110300229A1 (en) | 2011-12-08 |
CA2696035A1 (en) | 2009-02-12 |
EP2173364A4 (en) | 2010-11-24 |
CN102159223B (zh) | 2013-10-30 |
HK1160788A1 (en) | 2012-08-17 |
BRPI0814935A2 (pt) | 2015-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010001584A (es) | Tratamiento o prevencion de infeccion por rotavirus. | |
PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
EP2440210A4 (en) | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES | |
MY158504A (en) | Fatty acid niacin conjugates and their uses | |
EA201000322A1 (ru) | Композиции и способы для обработки семян | |
MX2020004099A (es) | Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo. | |
MX2009007266A (es) | Formulaciones estables de acido s-(+)-abscisico liquidas y de granulo soluble. | |
MX2011007930A (es) | Conjugados de insulina cristalina. | |
PH12013502370A1 (en) | Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
BR112014031914A2 (pt) | cápsula de estradiol solúvel para inserção vaginal | |
MX2009003911A (es) | Formulaciones de liberacion inmediata, mejoradas de topiramato. | |
EP2464724A4 (en) | COMPOSITIONS AND METHODS FOR IMPLANTATION OF TREATED ADIPOSE TISSUE AND TREATED ADIPOSE TISSUE PRODUCTS | |
UA109112C2 (uk) | Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями | |
MX2014004366A (es) | Aceleracion de la recuperacion muscular despues de la atrofia muscular inducida por inmovilizacion. | |
UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
GB2483419A (en) | Formulations for the treatment of deep tissue pain | |
MX2015015628A (es) | Acido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales. | |
MY148276A (en) | Long-term feed- elderly | |
MX2009011577A (es) | Composiciones y metodos para distribucion de domperidona a traves de la mucosa. | |
EP2579863A4 (en) | COMPOUNDS FOR THE TREATMENT OF BOVINE MASTITIS | |
IN2012DN03187A (es) | ||
EP2597949A4 (en) | SUBMIKROMETERZUSAMMENSETZUNGEN | |
MX2012004282A (es) | Composiciones farmaceuticas. | |
MX2009011817A (es) | Formulaciones de aminoacido n-halogenado que contienen acido alifatico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |